Skip to main content
logo
Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.7090
+0.0169 (2.44%)
At close: Sep 29, 2026, 4:00 PM EDT
0.6812
-0.0278 (-3.92%)
After-hours: Sep 29, 2026, 4:50 PM EDT

Envoy Medical Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q4 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Dec '21
Revenue
0.210.230.240.210.220.210.230.280.30.30.320.240.220.210.240.31
Revenue Growth
-6.76%10.38%7.11%-25.18%-26.49%-28.62%-28.80%15.35%38.53%38.78%33.33%----23.55%-
Gross Profit
-0.61-0.54-0.44-0.61-0.58-0.6-0.52-0.54-0.55-0.47-0.47-0.47-0.19-0.25-0.26-0.46
Operating Income
-23.43-22.93-22.08-20.43-19.7-19.48-19.26-21.43-19.84-19.47-18.36-14.54-12.95-10.67-8.71-6.87
Net Income
-28.46-28.13-28.66-28.61-28.2-26.57-27.97-26.53-17.72-25.65-31.27-36.5-38.32-26.81-15.92-8.68
Earnings Per Share
-0.51-0.80-1.23-1.36-1.40-1.36-1.49-1.43-1.07-1.78-2.54-3.60-0.28-0.19-1.57-0.86
EPS Growth
----------------

Cash & Debt
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q4 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Dec '21
Cash & Investments
19.6825.253.743.565.295.315.484.421.754.954.227.440.071.110.181.12
Total Debt
0.810.890.920.9528.8324.0319.6615.618.595.360.560.5956.6245.9434.5423.48
Net Cash (Debt)
18.8724.362.822.61-23.55-18.72-14.18-11.19-6.84-0.413.666.85-56.55-44.83-34.35-22.36
Net Cash Growth
----------------
Net Cash Per Share
0.340.690.120.12-1.17-0.96-0.75-0.60-0.41-0.030.300.68-0.41-0.32-3.39-2.21

Cash Flow & CapEx
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q4 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Dec '21
Operating Cash Flow
-21.53-20.54-18.2-17.61-15.9-16.09-17.95-24-20.28-19.67-17.09-8.33-11.9-9.84-8.81-6.94
Capital Expenditures
-0.18-0.17-0.180.53-0.09-0.88-0.98-1.54-0.98-0.2-0.15-0.17-0.19-0.25-0.22-0.13
Free Cash Flow
-21.71-20.71-18.38-17.08-15.99-16.96-18.93-25.54-21.26-19.87-17.24-8.5-12.09-10.09-9.02-7.06
Free Cash Flow Growth
----------------

Margins
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q4 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Dec '21
Gross Margin
-293.72%-229.49%-183.82%-294.23%-262.16%-284.43%-229.78%-194.60%-181.46%-158.25%-149.68%-192.95%-85.32%-114.95%-110.13%-148.06%
Operating Margin
-11319.32%-9800.00%-9161.83%-9824.04%-8872.97%-9188.21%-8558.22%-7708.63%-6570.53%-6556.23%-5809.81%-6034.02%-5941.74%-4984.58%-3673.42%-2216.45%
Pretax Margin
-11304.83%-9875.64%-9857.26%-10475.00%-9579.28%-9208.96%-9242.22%-7579.86%-4516.56%-7723.57%-9468.99%-15146.89%-18034.40%-12759.35%-6718.57%-2798.39%
Profit Margin
-13747.34%-12020.09%-11892.95%-13755.29%-12704.51%-12534.91%-12432.44%-9543.52%-5867.22%-8637.37%-9895.89%-15146.89%-17575.69%-12525.70%-6718.56%-2798.39%
FCF Margin
-10488.41%-8850.43%-7626.56%-8211.54%-7201.35%-8000.94%-8412.89%-9186.33%-7040.73%-6690.91%-5456.96%-3526.14%-5545.41%-4714.49%-3807.17%-2277.74%

Valuation
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q4 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Dec '21
PS Ratio
294.15218.5278.9788.80136.41130.78128.67229.14153.17258.03112.02569.066536.43---